CA
BHVN icon

Crewe Advisors’s Biohaven BHVN Stock Holding History

Crewe Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4
Closed -$172 – 941
2023
Q4 		$172 Buy
+4
New +$124 ﹤0.01% 363
2023
Q2 		– Sell
-15
Closed -$205 – 889
2023
Q1 		$205 Hold
15
– – ﹤0.01% 793
2022
Q4 		$208 Sell
15
-17
-53% -$240 ﹤0.01% 990
2022
Q3 		$5K Buy
+32
New +$232 ﹤0.01% 835

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Crewe Advisors's BHVN Position: Q1 2024 in Review

Crewe Advisors sold out of Biohaven (BHVN) in Q1 2024, closing a stake of 4 shares — an estimated $172 sold.

Crewe Advisors first reported a position in BHVN in Q3 2022 and held it in 4 quarters. The position peaked at $5K in Q3 2022. 243 funds tracked by Wall St. Rank hold BHVN as of Q1 2024.

  • Crewe Advisors reported no remaining Biohaven position as of Q1 2024 after selling out during the quarter.
  • Crewe Advisors sold 4 Biohaven shares in Q1 2024, an estimated $172.
  • Crewe Advisors first reported a position in Biohaven in Q3 2022 and held it in 4 quarters.
  • Crewe Advisors's Biohaven position peaked at $5K in Q3 2022.
  • 243 funds tracked by Wall St. Rank held Biohaven as of Q1 2024.

Based on Crewe Advisors's 13F filing for Q1 2024, filed 14 May 2024.